| P50 | author | Andrea Farini | Q96079880 |
| | Mirella Meregalli | Q53243014 |
| | Clementina Sitzia | Q64398315 |
| P2093 | author name string | Yvan Torrente | |
| | Silvia Erratico | |
| P2860 | cites work | Clinical applications of mesenchymal stem cells | Q21198864 |
| | Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells | Q24672061 |
| | Myogenic specification of side population cells in skeletal muscle | Q24672806 |
| | Expansion and redifferentiation of adult human pancreatic islet cells | Q46918992 |
| | Defining the risks of mesenchymal stromal cell therapy | Q47584701 |
| | Safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis. | Q47586113 |
| | Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases | Q47619959 |
| | Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells | Q47661065 |
| | Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro. | Q47894301 |
| | Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells | Q48000642 |
| | Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications | Q48088787 |
| | Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome | Q48198558 |
| | Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival | Q48371412 |
| | Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice | Q48497239 |
| | Combining erythropoietin infusion with intramyocardial delivery of bone marrow cells is more effective for cardiac repair. | Q50700769 |
| | Intracerebral transplantation of adipose-derived mesenchymal stem cells alternatively activates microglia and ameliorates neuropathological deficits in Alzheimer's disease mice. | Q50719528 |
| | A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs. | Q50780054 |
| | Flk-1+ adipose-derived mesenchymal stem cells differentiate into skeletal muscle satellite cells and ameliorate muscular dystrophy in mdx mice. | Q50866492 |
| | Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells | Q83586509 |
| | Mesenchymal stromal cells | Q84612117 |
| | TLR ligands stimulation protects MSC from NK killing | Q86524351 |
| | Multilineage potential of adult human mesenchymal stem cells | Q27860737 |
| | Stem cell therapy in a caprine model of osteoarthritis | Q28191365 |
| | Bone marrow cells regenerate infarcted myocardium | Q28210640 |
| | Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis | Q28295588 |
| | Epithelial-to-Mesenchymal Transition Generates Proliferative Human Islet Precursor Cells | Q29541158 |
| | Mesenchymal stem cells within tumour stroma promote breast cancer metastasis | Q29614303 |
| | Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study | Q29617267 |
| | Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells | Q29618766 |
| | Mesenchymal stem cells | Q29619804 |
| | Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production | Q29619807 |
| | No Evidence for Mouse Pancreatic -Cell Epithelial-Mesenchymal Transition In Vitro | Q30000016 |
| | Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. | Q30157916 |
| | Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood | Q30163911 |
| | Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies | Q30195546 |
| | Regulatory T cells in CNS injury: the simple, the complex and the confused | Q30424827 |
| | Strategies to rescue mesenchymal stem cells (MSCs) and dental pulp stem cells (DPSCs) from NK cell mediated cytotoxicity | Q30980207 |
| | Mobilized bone marrow cells repair the infarcted heart, improving function and survival | Q31002195 |
| | Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes | Q33181775 |
| | Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing | Q33326623 |
| | Bone-marrow-derived cells that home to acoustic deafened cochlea preserved their hematopoietic identity | Q33332228 |
| | Why are MSCs therapeutic? New data: new insight. | Q33386080 |
| | Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner | Q33438830 |
| | Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha | Q33564990 |
| | IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis | Q33769303 |
| | Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice | Q33811436 |
| | Cardiomyocytes can be generated from marrow stromal cells in vitro | Q33843659 |
| | Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta | Q33855709 |
| | Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. | Q34007524 |
| | Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery | Q34012747 |
| | Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone | Q34066339 |
| | Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study | Q34132522 |
| | SHED: stem cells from human exfoliated deciduous teeth. | Q34193093 |
| | Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial | Q34332467 |
| | Stem cells in tissue engineering. | Q34426497 |
| | Potential of rat bone marrow-derived mesenchymal stem cells as vehicles for delivery of neurotrophins to the Parkinsonian rat brain | Q39664348 |
| | Immunosuppressive effects of mesenchymal stem cells in collagen-induced mouse arthritis | Q39797982 |
| | The effect of continued hypoxia on rat pulmonary arterial circulation. An ultrastructural study | Q39844907 |
| | Lentiviral delivery of LMX1a enhances dopaminergic phenotype in differentiated human bone marrow mesenchymal stem cells | Q39993972 |
| | Dopaminergic differentiation of human mesenchymal stem cells--utilization of bioassay for tyrosine hydroxylase expression | Q40138132 |
| | Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis | Q40144569 |
| | Mobilization of endothelial progenitor cells into the circulation in burned patients | Q40183091 |
| | Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes | Q40574948 |
| | Phenotypic determination and characterization of nestin-positive precursors derived from human fetal pancreas. | Q40594090 |
| | Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis | Q40727194 |
| | Importance of the SDF-1:CXCR4 axis in myocardial repair | Q42570987 |
| | Modeling familial Alzheimer's disease with induced pluripotent stem cells | Q42817521 |
| | Human mesenchymal stem cells infiltrate the spinal cord, reduce demyelination, and localize to white matter lesions in experimental autoimmune encephalomyelitis. | Q43578851 |
| | The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. | Q43599448 |
| | Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo | Q44124588 |
| | Neutrophils do not contribute to local tissue damage, but play a key role in skeletal muscle regeneration, in mice injected with Bothrops asper snake venom | Q44594506 |
| | Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. | Q44960426 |
| | Human umbilical cord blood cells differentiate into muscle in sjl muscular dystrophy mice | Q45145866 |
| | Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. | Q45152925 |
| | Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion. | Q45888978 |
| | Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burns | Q45889492 |
| | Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. | Q46004819 |
| | Experimental study on influence of bone marrow mesenchymal stem cells on activation and function of mouse peritoneal macrophages | Q46180763 |
| | Enhanced expression of the CXCl12/SDF-1 chemokine receptor CXCR7 after cerebral ischemia in the rat brain | Q46566592 |
| | Dynamic distribution of bone marrow-derived mesenchymal stromal cells and change of pathology after infusing into mdx mice | Q46639962 |
| | Fibroblast precursors in normal and irradiated mouse hematopoietic organs | Q34474362 |
| | Human Thymus Mesenchymal Stromal Cells Augment Force Production in Self-Organized Cardiac Tissue | Q34495019 |
| | Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis | Q34564111 |
| | Systemic transplantation of human umbilical cord derived mesenchymal stem cells-educated T regulatory cells improved the impaired cognition in AβPPswe/PS1dE9 transgenic mice | Q34919216 |
| | In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion | Q34967985 |
| | Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects | Q35168236 |
| | Cell therapy for bone disease: a review of current status | Q35216533 |
| | Mesenchymal stem cells enhance autophagy and increase β-amyloid clearance in Alzheimer disease models. | Q35319897 |
| | Islet transplantation: immunological perspectives | Q35538149 |
| | Cord blood in regenerative medicine: do we need immune suppression? | Q35633105 |
| | Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation | Q35665181 |
| | Mesenchymal stem cells: clinical applications and biological characterization. | Q35686355 |
| | Mesenchymal stem cells: isolation and therapeutics | Q35877577 |
| | Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus | Q35879759 |
| | Autologous haematopoietic-stem-cell transplantation for multiple sclerosis | Q35994389 |
| | Mesenchymal stem cells: progress toward promise | Q36205474 |
| | Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration | Q36324366 |
| | Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. | Q36325014 |
| | Mesenchymal stem cells: isolation, in vitro expansion and characterization | Q36349210 |
| | Parkinson's disease: pathophysiology | Q36495393 |
| | Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1. | Q36547021 |
| | Immune regulation by mesenchymal stem cells: two sides to the coin | Q36703067 |
| | Mesenchymal stem cells: a new strategy for immunosuppression? | Q36776872 |
| | Modulation of immune responses by mesenchymal stem cells | Q36795173 |
| | Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue | Q37132476 |
| | Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells | Q37134013 |
| | Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS | Q37183861 |
| | Mesenchymal stem cell homing: the devil is in the details | Q37407769 |
| | Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration | Q37537193 |
| | Biomolecular strategies of bone augmentation in spinal surgery | Q37825049 |
| | Role of adult stem/progenitor cells in osseointegration and implant loosening | Q37861558 |
| | Bioreactor systems for bone tissue engineering | Q37865539 |
| | Recent preclinical evidence advancing cell therapy for Alzheimer's disease. | Q38024220 |
| | T cells out of control--impaired immune regulation in the inflamed joint | Q38079816 |
| | Tissue-engineered approach for the treatment of steroid-induced osteonecrosis of the femoral head: transplantation of autologous mesenchymal stem cells cultured with beta-tricalcium phosphate ceramics and free vascularized fibula. | Q51092429 |
| | Healos and bone marrow aspirate used for lumbar spine fusion: a case controlled study comparing healos with autograft. | Q51144517 |
| | CNS microvascular pericytes exhibit multipotential stem cell activity. | Q51285884 |
| | Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. | Q51371194 |
| | Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. | Q51474101 |
| | Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. | Q51638429 |
| | Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. | Q51898878 |
| | Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. | Q51972063 |
| | Widespread distribution and muscle differentiation of human fetal mesenchymal stem cells after intrauterine transplantation in dystrophic mdx mouse. | Q51998594 |
| | Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice. | Q53532396 |
| | Islet-derived fibroblast-like cells are not derived via epithelial-mesenchymal transition from Pdx-1 or insulin-positive cells. | Q53587915 |
| | Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. | Q53628210 |
| | Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. | Q53652498 |
| | Marrow stromal stem cells. | Q54130286 |
| | Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. | Q54493066 |
| | Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. | Q54656483 |
| | Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells | Q57702376 |
| | Pretransplant Infusion of Mesenchymal Stem Cells Prolongs the Survival of a Semiallogeneic Heart Transplant through the Generation of Regulatory T Cells | Q57702466 |
| | PD1 Negative and PD1 Positive CD4+ T Regulatory Cells in Mild Cognitive Impairment and Alzheimer's Disease | Q57997425 |
| | Interleukin-10 inhibition of the progression of established collagen-induced arthritis | Q58479922 |
| | Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide | Q61645540 |
| | Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals | Q62083511 |
| | Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease | Q63197317 |
| | Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use | Q70803151 |
| | In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells | Q73702569 |
| | Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice | Q73850247 |
| | Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects | Q74341231 |
| | Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus | Q80082586 |
| | Abnormal surface markers expression on bone marrow CD34+ cells and correlation with disease activity in patients with systemic lupus erythematosus | Q80188870 |
| | Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction | Q80246358 |
| | [Cell based therapy for the treatment of femoral head necrosis] | Q80265662 |
| | Immunosuppression by placental indoleamine 2,3-dioxygenase: a role for mesenchymal stem cells | Q80832925 |
| | Prospective identification of myogenic endothelial cells in human skeletal muscle | Q80982228 |
| | Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis | Q81277810 |
| | Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: role of NKp30 and NKG2D receptors | Q81447005 |
| | A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1 | Q81596726 |
| | Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression | Q81667319 |
| | Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium | Q81845589 |
| | [Clinical study of lumbar fusion by hybrid construct of stem cells technique and biodegradable material] | Q81953551 |
| | Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patients with chronic myeloid leukemia | Q82095655 |
| | Flk-1+ mesenchymal stem cells aggravate collagen-induced arthritis by up-regulating interleukin-6 | Q82209428 |
| | Human bone marrow-derived mesenchymal cells differentiate and mature into endocrine pancreatic lineage in vivo | Q82253464 |
| | Generation of glucose-responsive, insulin-producing cells from human umbilical cord blood-derived mesenchymal stem cells | Q83126621 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| P304 | page(s) | 306573 | |
| P577 | publication date | 2014-04-30 | |
| P1433 | published in | Stem Cells International | Q26842114 |
| P1476 | title | Clinical applications of mesenchymal stem cells in chronic diseases | |
| P478 | volume | 2014 | |